{"title":"自动植入式除颤器。","authors":"R N Fogoros","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The automatic implantable defibrillator is undergoing clinical trials in the United States. The device is a self-contained unit designed to detect malignant ventricular arrhythmias as they occur and to terminate them with a defibrillating current. Early clinical trials demonstrate its safety and effectiveness in terminating ventricular tachyarrythmias as well as its ability to reduce markedly the incidence of sudden cardiac death in high-risk patients. Continued refinements should further improve reliability and safety of the device.</p>","PeriodicalId":79863,"journal":{"name":"CVP","volume":"12 1","pages":"13, 16-8"},"PeriodicalIF":0.0000,"publicationDate":"1983-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The automatic implantable defibrillator.\",\"authors\":\"R N Fogoros\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The automatic implantable defibrillator is undergoing clinical trials in the United States. The device is a self-contained unit designed to detect malignant ventricular arrhythmias as they occur and to terminate them with a defibrillating current. Early clinical trials demonstrate its safety and effectiveness in terminating ventricular tachyarrythmias as well as its ability to reduce markedly the incidence of sudden cardiac death in high-risk patients. Continued refinements should further improve reliability and safety of the device.</p>\",\"PeriodicalId\":79863,\"journal\":{\"name\":\"CVP\",\"volume\":\"12 1\",\"pages\":\"13, 16-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1983-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CVP\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CVP","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The automatic implantable defibrillator is undergoing clinical trials in the United States. The device is a self-contained unit designed to detect malignant ventricular arrhythmias as they occur and to terminate them with a defibrillating current. Early clinical trials demonstrate its safety and effectiveness in terminating ventricular tachyarrythmias as well as its ability to reduce markedly the incidence of sudden cardiac death in high-risk patients. Continued refinements should further improve reliability and safety of the device.